The EU Clinical Trials Regulation: one step forward, two steps back?
This article was originally published in SRA
Executive Summary
The new EU Clinical Trials Regulation has had a largely positive reception, but it leaves a lot of questions unanswered. Indeed, argues John Lisman, in some important areas it fails to improve on the legislation it is replacing.